You are here

Ziprasidone And Olanzapine's Outcomes In Mania

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Aachen, , 52074 Germany
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Acute Mania, Manic Bipolar Disorder
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Have a primary diagnosis of Bipolar I Disorder, current episode manic (DSM-IV 296.4x)
or mixed (DSM-IV296.6x) as determined by a structured clinical interview (Mini
International Neuropsychiatric Interview (MINI)) at screening.

- A minimum score of 20 on the YMRS (Youngs Mania Rating Scale).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Have a diagnosis of learning disability or organic brain syndrome.

- Have a substance-induced psychotic disorder or behavioral disturbance thought to be
due to substance abuse.

NCT00329108
Pfizer
Terminated
Ziprasidone And Olanzapine's Outcomes In Mania

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now